Companion Diagnostic Tests in Oncology Market Is Anticipated to Rise at an Outstanding 16.8% CAGR from 2017 to 2025
The degree of competition in the global companion diagnostic tests in oncology market for is likely to range from moderate to high owing to the fact that numerous manufacturers are looking forward to collaborate with several pharmaceutical manufacturers, states Transparency Market Research (TMR) in a research report. Moreover, the rising number of vendors in the market with several cutting edge technologies is also anticipated to put the position of established players at stake in the years ahead.
View full press release